Cargando…
Lymphadenectomy for Upper Tract Urothelial Carcinoma: A Systematic Review
Background: The role of lymphonodal dissection during surgery for a tumor of the urinary tract remains controversial. Objective: To analyze anatomical bases of lymphonodal dissection in tumors of the upper urinary tract and analyze its impact on survival, recurrence, and staging. Acquisition of data...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6722659/ https://www.ncbi.nlm.nih.gov/pubmed/31398895 http://dx.doi.org/10.3390/jcm8081190 |
_version_ | 1783448589538689024 |
---|---|
author | Duquesne, Igor Ouzaid, Idir Loriot, Yohann Moschini, Marco Xylinas, Evanguelos |
author_facet | Duquesne, Igor Ouzaid, Idir Loriot, Yohann Moschini, Marco Xylinas, Evanguelos |
author_sort | Duquesne, Igor |
collection | PubMed |
description | Background: The role of lymphonodal dissection during surgery for a tumor of the urinary tract remains controversial. Objective: To analyze anatomical bases of lymphonodal dissection in tumors of the upper urinary tract and analyze its impact on survival, recurrence, and staging. Acquisition of data: A web-based search for scientific articles using Medline/Pubmed was carried out to identify and analyze articles on the practice and the role of lymphonodal dissection in this indication. Data Synthesis: The lymphatic drainage of the upper urinary tract has rarely been studied and is poorly understood. The lymphonodal metastatic extension is the most common extension in upper urinary tract urothelial carcinoma. Lymphnode invasion is a clear independent poor prognostic factor. Therefore, it seems legitimate to offer an extended lymphonodal dissection to patients undergoing surgery to cure these tumors. When lymphnodes dissection respects clear anatomical principles based on the location of the primary tumor and its extension, it improves both survival and recurrence rates. This result could be secondary to the treatment of subclinical metastatic disease. Conclusion: An extended lymphadenectomy during surgery for upper urinary tract urothelial carcinoma following strict anatomical pattern improves staging with a highly probable therapeutic benefit. |
format | Online Article Text |
id | pubmed-6722659 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-67226592019-09-10 Lymphadenectomy for Upper Tract Urothelial Carcinoma: A Systematic Review Duquesne, Igor Ouzaid, Idir Loriot, Yohann Moschini, Marco Xylinas, Evanguelos J Clin Med Review Background: The role of lymphonodal dissection during surgery for a tumor of the urinary tract remains controversial. Objective: To analyze anatomical bases of lymphonodal dissection in tumors of the upper urinary tract and analyze its impact on survival, recurrence, and staging. Acquisition of data: A web-based search for scientific articles using Medline/Pubmed was carried out to identify and analyze articles on the practice and the role of lymphonodal dissection in this indication. Data Synthesis: The lymphatic drainage of the upper urinary tract has rarely been studied and is poorly understood. The lymphonodal metastatic extension is the most common extension in upper urinary tract urothelial carcinoma. Lymphnode invasion is a clear independent poor prognostic factor. Therefore, it seems legitimate to offer an extended lymphonodal dissection to patients undergoing surgery to cure these tumors. When lymphnodes dissection respects clear anatomical principles based on the location of the primary tumor and its extension, it improves both survival and recurrence rates. This result could be secondary to the treatment of subclinical metastatic disease. Conclusion: An extended lymphadenectomy during surgery for upper urinary tract urothelial carcinoma following strict anatomical pattern improves staging with a highly probable therapeutic benefit. MDPI 2019-08-08 /pmc/articles/PMC6722659/ /pubmed/31398895 http://dx.doi.org/10.3390/jcm8081190 Text en © 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Duquesne, Igor Ouzaid, Idir Loriot, Yohann Moschini, Marco Xylinas, Evanguelos Lymphadenectomy for Upper Tract Urothelial Carcinoma: A Systematic Review |
title | Lymphadenectomy for Upper Tract Urothelial Carcinoma: A Systematic Review |
title_full | Lymphadenectomy for Upper Tract Urothelial Carcinoma: A Systematic Review |
title_fullStr | Lymphadenectomy for Upper Tract Urothelial Carcinoma: A Systematic Review |
title_full_unstemmed | Lymphadenectomy for Upper Tract Urothelial Carcinoma: A Systematic Review |
title_short | Lymphadenectomy for Upper Tract Urothelial Carcinoma: A Systematic Review |
title_sort | lymphadenectomy for upper tract urothelial carcinoma: a systematic review |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6722659/ https://www.ncbi.nlm.nih.gov/pubmed/31398895 http://dx.doi.org/10.3390/jcm8081190 |
work_keys_str_mv | AT duquesneigor lymphadenectomyforuppertracturothelialcarcinomaasystematicreview AT ouzaididir lymphadenectomyforuppertracturothelialcarcinomaasystematicreview AT loriotyohann lymphadenectomyforuppertracturothelialcarcinomaasystematicreview AT moschinimarco lymphadenectomyforuppertracturothelialcarcinomaasystematicreview AT xylinasevanguelos lymphadenectomyforuppertracturothelialcarcinomaasystematicreview |